Cerebrolysin vs Oxiracetam for memory
Short answer: For memory, users rate them about the same: 96% report improvement with Cerebrolysin (24 reports) and 100% with Oxiracetam (23 reports).
Cerebrolysin has 30 meta-analyses and 60 randomized trials on PubMed; Oxiracetam has 5 and 19.
Based on 196 reports about Cerebrolysin and 254 about Oxiracetam. Not medical advice.
| Cerebrolysin Peptide | Oxiracetam Supplement | |
|---|---|---|
| User score | 49 | 49 |
| Verdict | Mostly positive | Mostly positive |
| Positive of reports that state an outcome | 75% | 69% |
| Reports | 196 | 254 |
| Research | AResearch: Strong | AResearch: Strong |
| Meta-analyses / RCTs | 30 / 60 | 5 / 19 |
| Mainly used for | ||
| Focus % reporting improvement | 90% (21) | 91% (55) |
| Energy % reporting improvement | 88% (8) | 100% (14) |
| Sleep % reporting improvement | 100% (5) | — |
| Anxiety % reporting improvement | 89% (9) | 62% (8) |
| Mood % reporting improvement | 90% (20) | 64% (11) |
| Memory % reporting improvement | 96% (24) | 100% (23) |
| Performance % reporting improvement | — | 100% (5) |
| Recovery % reporting improvement | 100% (3) | — |
| Pain & inflammation % reporting improvement | 100% (2) | — |
| Common side effects | brain fog, fatigue, headache, tingling | hypomania, brain fog, anxiety, tolerance |
| Typical dose reported | Not listed | as needed |
Ginkgo biloba extracts have shown the greatest cognitive and functional benefits, though their clinical significance remains uncertain, and certainty of evidence is overall low. Future trials should focus on a single VCI subtype, prioritize interventions with a strong mechanistic rationale, standardize diagnostic criteria, ensure adequate power for chosen outcomes, test against placebo, and implement FAIR data sharing to accelerate therapeutic discovery.
Alzheimers Dement, 2025 ↗“Cerebrolysin is by far the best nootropic I have ever used...my memory, recall ability, sensitivity to music, observance over my emotions, thinking faculties have all improved to a noticeable amount.”
This study enhances the understanding of the relative benefits and risks associated with various VaD treatments, providing a valuable reference for clinical decision-making.
Front Pharmacol, 2024 ↗“Oxi gave me a significant increase in focus, to the point where I could work for 2-3 hours without even checking facebook. / It also helped me with memory (was clearly retaining more info in both short-term and long-term).”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate